Table 3. Sensitivity Analysis: Summary Estimates of Subgroups After Removing Discontinued FITs.
| Variable | Studies, n | Sensitivity (95% CI) | I2* | Between-Study Variance in Logit Sensitivity | Specificity (95% CI) | I2* | Between-Study Variance in Logit Specificity | Positive LR (95% CI) | I2* | Negative LR (95% CI) | I2* |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FIT sample | |||||||||||
|
| |||||||||||
| 1-sample | 11 | 0.78 (0.65–0.87) | 58.1 | 0.63 | 0.94 (0.92–0.95) | 98.2 | 0.17 | 12.8 (10.8–15.1) | 85.9 | 0.23 (0.14–0.38) | 49.8 |
|
| |||||||||||
| 2-sample† | 4 | 0.77 (0.59–0.89) | 61.1 | 0.43 | 0.93 (0.90–0.95) | 98.7 | 0.17 | 11.2 (6.5–19.5) | 89.0 | 0.25 (0.13–0.49) | 73.9 |
|
| |||||||||||
| 3-sample | 6 | 0.80 (0.66–0.89) | 5.2 | 0.07 | 0.93 (0.89–0.95) | 97.7 | 0.30 | 11.3 (7.4–17.5) | 88.4 | 0.21 (0.12–0.38) | 0 |
|
| |||||||||||
| FIT cutoff value for a positive test result | |||||||||||
| <20 μg/g | 9 | 0.89 (0.80–0.95) | 26.4 | 0.32 | 0.91 (0.89–0.93) | 94.9 | 0.12 | 10.2 (8.3–12.3) | 75.2 | 0.12 (0.06–0.22) | 14.5 |
|
| |||||||||||
| 20–50 μg/g | 5 | 0.70 (0.55–0.81) | 0 | 0.10 | 0.95 (0.95–0.96) | 82.0 | 0.03 | 15.3 (12.5–18.8) | 0 | 0.32 (0.21–0.49) | 0 |
|
| |||||||||||
| >50 μg/g | 4 | 0.67 (0.59–0.74) | 33.2 | 0.00 | 0.96 (0.94–0.98) | 99.2 | 0.24 | 18.7 (11.7–29.8) | 92.2 | 0.34 (0.27–0.43) | 37.6 |
| FIT brand | |||||||||||
|
| |||||||||||
| OC-Micro/Sensor | 5 | 0.86 (0.68–0.95) | 0 | 0.28 | 0.91 (0.87–0.94) | 95.5 | 0.21 | 9.7 (6.8–13.9) | 54.4 | 0.16 (0.06–0.38) | 0 |
|
| |||||||||||
| OC-Light | 4 | 0.93 (0.83–0.97) | 26.6 | 0.07 | 0.91 (0.88–0.92) | 95.9 | 0.06 | 9.9 (8.0–12.2) | 85.7 | 0.08 (0.03–0.20) | 9.99 |
| Reference standard | |||||||||||
|
| |||||||||||
| Colonoscopy | 10 | 0.77 (0.65–0.86) | 45.7 | 0.60 | 0.93 (0.91–0.95) | 98.2 | 0.21 | 11.6 (9.6–14.0) | 78.9 | 0.25 (0.16–0.39) | 27.1 |
|
| |||||||||||
| 2-y follow-up‡ | 5 | 0.91 (0.78–0.97) | 0 | 0.52 | 0.94 (0.91–0.96) | 97.9 | 0.25 | 15.6 (10.8–22.7) | 88.0 | 0.09 (0.03–0.25) | 0 |
FIT = fecal immunochemical test; LR = likelihood ratio.
Inconsistency index minus the measure of heterogeneity.
Unable to do a sensitivity analysis because of the lack of data sets/studies.
At least a 2-y longitudinal follow-up with medical records or cancer registry.